10.1016/j.bbr.2020.112919 Summary Keywords retina, ischemia, BPC 157, L-NAME, rats Citation Zlatar M, Kokot A, Vuletic LB, Masnec S, Kralj T, Perisa MM, Barisic I, Radic B, Milanovic K, Drmic D, Seiwerth S and Sikiric P (2021) BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats
The human equivalent of roughly 0.035 mg represents a tiny fraction of the standard skin rejuvenation dose, suggesting that neurological benefits may occur alongside skin improvements at typical protocol dosages
Gastrointestinal Support: BPC-157 shows gastroprotective and ulcer-healing effects in preclinical studies [2]
The preclinical evidence consistently shows enhanced healing across multiple tissue types relevant to shoulder injuries
Past 28 days, risks rise as the preservative loses strength